Uncovering the pharmacological mechanism of Shou Tai Wan on recurrent spontaneous abortion : A integrated pharmacology strategy-based research

Copyright © 2023 Elsevier B.V. All rights reserved..

ETHNOPHARMACOLOGICAL RELEVANCE: Shou Tai Wan (STW), a traditional Chinese medicine formula, has been historically used for the treatment of recurrent spontaneous abortion (RSA). Despite its long-standing usage, the exact mechanism underlying the therapeutic effects of STW remains unclear in the existing literature.

AIMS OF THIS STUDY: To explore the Pharmacological Mechanism of STW on RSA.

METHODS: A network pharmacological methodology was utilized to predict the active compounds and potential targets of STW, collect the RSA targets and other human proteins of STW, and analyze the STW related networks. The animal experiments were also performed to validate the effect of STW on RSA.

RESULTS: The results of network analysis showed that STW may regulate PI3K/AKT, MAPK, FoxO signaling pathways and so on. Animal experiment established the RSA model with CBA/J × DBA/2 mice. It was found that STW can reduce the embryo absorption rate of RSA group (p < 0.05) and balance the expression of Th 1/Th2 type cytokines compared with the model group. After 14 days of administration, the decidual and placental tissues were taken and the CD4+ T cells were isolated, and the phosphorylation level of signaling pathway was detected by Springbio720 antibody microarray. This experiment found that STW can significantly up-regulate the phosphorylation levels of STAT3 and STAT6 proteins in the STAT signaling pathway, and down-regulating the phosphorylation level of STAT1 protein. STW also significantly up-regulated the phosphorylation levels of Raf1, A-Raf, Ask1, Mek1, Mek2, JKK1, ERK1, ERK2, c-fos, c-Jun and CREB proteins in the MAPK signaling pathway, and down-regulate the phosphorylation levels of MEK6 and IKKb proteins. Compared with the RSA group, the STW group increased the expression levels of ERK1/2 mRNA and proteins and p-ERK1/2 proteins, and there was a statistical difference (p < 0.05). This is consistent with the chip results.

CONCLUSION: STW may achieve therapeutic effects by interfering with the signaling pathways, biological processes and targets discovered in this study. It provides a new perspective for revealing the immunological mechanism of STW in the treatment of RSA, and also provides a theoretical basis for the clinical use of STW in the treatment of RSA.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:323

Enthalten in:

Journal of ethnopharmacology - 323(2024) vom: 06. Jan., Seite 117589

Sprache:

Englisch

Beteiligte Personen:

Yang, Kailin [VerfasserIn]
Zeng, Liuting [VerfasserIn]
Li, Yuwei [VerfasserIn]
Wu, Lingyu [VerfasserIn]
Xiang, Wang [VerfasserIn]
Wu, Xiaolan [VerfasserIn]
Wang, Guiyun [VerfasserIn]
Bao, Tingting [VerfasserIn]
Huang, Shanshan [VerfasserIn]
Yu, Rong [VerfasserIn]
Zhang, Guomin [VerfasserIn]
Liu, Huiping [VerfasserIn]

Links:

Volltext

Themen:

Chinese medicine
EC 2.7.1.-
Integrated pharmacology
Journal Article
Phosphatidylinositol 3-Kinases
Recurrent spontaneous abortion
Shou Tai Wan
Th 1/Th2 type cytokines

Anmerkungen:

Date Completed 29.01.2024

Date Revised 29.01.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jep.2023.117589

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM365955760